The company recently pivoted from the entertainment and media sector to the wholesale trading of agricultural commodities, including wheat, rice, paddy, and pulses, as well as energy drinks and beverages.
The company operates as a commodity trader in a highly fragmented market with no identifiable competitive advantages. Low returns on capital and a total lack of proprietary technology or brand strength indicate that the business is a price-taker with no barrier to entry.
Management has shifted capital from a dormant entertainment business into unsecured loans to third parties and a new commodity trading venture. The high volume of loans to 'others' relative to the small asset base suggests a lack of focus on core business reinvestment.
The company's pivot from entertainment to commodity trading proved to be a value-destructive shell game. The capital previously tied up in unsecured loans to third parties was never recovered, and the SEBI restraint order effectively paralyzed the firm's ability to access capital markets or execute strategic shifts. Without any proprietary advantage or internal controls, the business succumbed to the inherent volatility of the agri-commodity market, while the lack of an internal auditor allowed operational inefficiencies and potential leakages to drain the remaining equity.
RichFakir rates Purple Agrotech Industries Ltd's business quality as poor — 17/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Purple Agrotech Industries Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Purple Agrotech Industries Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Purple Agrotech Industries Ltd's fair value is about ₹2 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →